Structural Correlates of Antibacterial and Membrane-Permeabilizing Activities in Acylpolyamines
Author(s) -
Rajalakshmi Balakrishna,
Stewart J. Wood,
Thuan B. Nguyen,
Kelly A. Miller,
E. V. K. Suresh Kumar,
Apurba Datta,
Sunil A. David
Publication year - 2006
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.50.3.852-861.2006
Subject(s) - antimicrobial , escherichia coli , spermine , cationic polymerization , biochemistry , membrane , amphiphile , cytotoxicity , antibacterial activity , chemistry , lipopolysaccharide , bovine serum albumin , antibiotics , biology , bacteria , in vitro , microbiology and biotechnology , enzyme , organic chemistry , genetics , copolymer , gene , endocrinology , polymer
A homologous series of mono- and bis-acyl polyamines with varying acyl chain lengths originally synthesized for the purpose of sequestering lipopolysaccharide were evaluated for antimicrobial activity to test the hypothesis that these bis-cationic amphipathic compounds may also bind to and permeabilize intact gram-negative bacterial membranes. Some compounds were found to possess significant antimicrobial activity, mediated via permeabilization of bacterial membranes. Structure-activity relationship studies revealed a strong dependence of the acyl chain length on antimicrobial potency and permeabilization activity. Homologated spermine, bis-acylated with C8 or C9 chains, was found to profoundly sensitize Escherichia coli to hydrophobic antibiotics such as rifampin. Nonspecific cytotoxicity is a potential drawback of these membranophilic compounds. However, the surface activity of these cationic amphipaths is strongly attenuated under physiological conditions via binding to serum albumin. Significant antibacterial activity is still retained in the presence of physiological concentrations of human serum albumin, suggesting that these compounds may serve as leads in the development of novel adjuncts to conventional antimicrobial chemotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom